Table 2.
Antimicrobial susceptibility (%) of 86 strains of MDR Acinetobacter baumannii isolates
| Antibiotics agents | CRAB | CSAB | Total |
|---|---|---|---|
| (n = 66) | (n = 20) | (n = 86) | |
| ampicillin | 0 (0/66) | 0 (0/20) | 0 (0/86) |
| ampicillin/sulbactam | 0 (0/66) | 0 (0/20) | 0 (0/86) |
| piperacillin/tazobactam | 0 (0/66) | 80.0 (16/20) | 18.6 (16/86) |
| cefotaxime | 0 (0/66) | 0 (0/20) | 0 (0/86) |
| ceftazidime | 0 (0/66) | 10.0 (2/20) | 2.33 (2/86) |
| cefepime | 0 (0/66) | 30.0 (6/20) | 6.98 (6/86) |
| aztreonam | 0 (0/66) | 30.0 (6/20) | 6.98 (6/86) |
| imipenem | 0 (0/66) | 100 (20/20) | 23.3 (20/86) |
| amikacin | 0 (0/66) | 100 (20/20) | 23.3 (20/86) |
| gentamicin | 0 (0/66) | 80.0 (16/20) | 18.6 (16/86) |
| ciprofloxacin | 0 (0/66) | 75.0 (15/20) | 17.4 (15/86) |
| levofloxacin | 0 (0/66) | 80.0 (16/20) | 18.6 (16/86) |
| trimethoprim/sulfamethoxazole | 0 (0/66) | 75.0 (15/20) | 17.4 (15/86) |
| tigecycline | 100 (66/66) | 100 (20/20) | 100 (100/100) |